Literature DB >> 23750754

Cryptocaryols A and B: total syntheses, stereochemical revision, structure elucidation, and structure-activity relationship.

Yanping Wang1, George A O'Doherty.   

Abstract

The first total syntheses and structural elucidation of cryptocaryol A and cryptocaryol B were achieved in 23 and 25 linear steps, respectively. The synthesis relied on the use of a key pseudo-Cs symmetric pentaol intermediate, which in a stereochemically divergent manner was converted into either enantiomer as well as diastereomers. This synthetic effort enabled the first structure-activity relationships of this class of PDCD4 stabilizing natural products.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23750754      PMCID: PMC3772640          DOI: 10.1021/ja404401f

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  32 in total

1.  An enantioselective synthesis of tarchonanthuslactone.

Authors:  Sarah D Garaas; Thomas J Hunter; George A O'Doherty
Journal:  J Org Chem       Date:  2002-04-19       Impact factor: 4.354

2.  An enantioselective synthesis of benzylidene-protected syn-3,5-dihydroxy carboxylate esters via osmium, palladium, and base catalysis.

Authors:  T J Hunter; G A O'Doherty
Journal:  Org Lett       Date:  2001-04-05       Impact factor: 6.005

3.  The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.

Authors:  Hsin-Sheng Yang; Aaron P Jansen; Anton A Komar; Xiaojing Zheng; William C Merrick; Sylvain Costes; Stephen J Lockett; Nahum Sonenberg; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

4.  De novo synthesis of 2-substituted syn-1,3-diols via an iterative asymmetric hydration strategy.

Authors:  Md Moinuddin Ahmed; Matthew S Mortensen; George A O'Doherty
Journal:  J Org Chem       Date:  2006-09-29       Impact factor: 4.354

5.  An enantioselective synthesis of cryptocarya diacetate.

Authors:  T J Hunter; G A O'Doherty
Journal:  Org Lett       Date:  2001-08-23       Impact factor: 6.005

6.  Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.

Authors:  Alexey Palamarchuk; Alexey Efanov; Vadim Maximov; Rami I Aqeilan; Carlo M Croce; Yuri Pekarsky
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

7.  Development of a high-throughput cell-based reporter assay for screening of JAK3 inhibitors.

Authors:  Chang-Hong Yin; Erika A Bach; Gyeong-Hun Baeg
Journal:  J Biomol Screen       Date:  2011-03-10

8.  Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.

Authors:  Lisa B Frankel; Nanna R Christoffersen; Anders Jacobsen; Morten Lindow; Anders Krogh; Anders H Lund
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

9.  Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.

Authors:  Olubunmi Afonja; Dominique Juste; Sharmistha Das; Sachiko Matsuhashi; Herbert H Samuels
Journal:  Oncogene       Date:  2004-10-21       Impact factor: 9.867

10.  Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity.

Authors:  Aaron P Jansen; Corinne E Camalier; Cristi Stark; Nancy H Colburn
Journal:  Mol Cancer Ther       Date:  2004-02       Impact factor: 6.261

View more
  10 in total

1.  Total and Formal Syntheses of Fostriecin.

Authors:  Gao Dong; Bohui Li; George O'Doherty
Journal:  Org Chem Front       Date:  2020-10-12       Impact factor: 5.281

Review 2.  Feedstock Reagents in Metal-Catalyzed Carbonyl Reductive Coupling: Minimizing Preactivation for Efficiency in Target-Oriented Synthesis.

Authors:  Rosalie S Doerksen; Cole C Meyer; Michael J Krische
Journal:  Angew Chem Int Ed Engl       Date:  2019-07-26       Impact factor: 15.336

3.  Cryptocaryol Structure-Activity Relationship Study of Cancer Cell Cytotoxicity and Ability to Stabilize PDCD4.

Authors:  Michael F Cuccarese; Yanping Wang; Penny J Beuning; George A O'Doherty
Journal:  ACS Med Chem Lett       Date:  2014-02-17       Impact factor: 4.345

4.  Synthesis and direct comparison of the anticancer activities of phomopsolides D and E and two 7-oxa-/7-aza-analogues.

Authors:  Alhanouf Z Aljahdali; Seth A Freedman; Jana Scott; Miaosheng Li; George A O'Doherty
Journal:  Medchemcomm       Date:  2019-05-08       Impact factor: 3.597

5.  Enantioselective Alcohol C-H Functionalization for Polyketide Construction: Unlocking Redox-Economy and Site-Selectivity for Ideal Chemical Synthesis.

Authors:  Jiajie Feng; Zachary A Kasun; Michael J Krische
Journal:  J Am Chem Soc       Date:  2016-04-26       Impact factor: 15.419

6.  Approach to the Synthesis of the C1-C11 and C14-C18 portion of Leucascandrolide A.

Authors:  T J Hunter; J Zheng; G A O'Doherty
Journal:  Org Chem Front       Date:  2016-07-12       Impact factor: 5.281

7.  Total Synthesis of Cryptocaryol A by Enantioselective Iridium-Catalyzed Alcohol C-H Allylation.

Authors:  Felix Perez; Andrew R Waldeck; Michael J Krische
Journal:  Angew Chem Int Ed Engl       Date:  2016-03-11       Impact factor: 15.336

8.  Total synthesis of tetrahydrolipstatin and stereoisomers via a highly regio- and diastereoselective carbonylation of epoxyhomoallylic alcohols.

Authors:  Michael Mulzer; Brandon J Tiegs; Yanping Wang; Geoffrey W Coates; George A O'Doherty
Journal:  J Am Chem Soc       Date:  2014-07-18       Impact factor: 15.419

9.  Tricyclic guanidine alkaloids from the marine sponge Acanthella cavernosa that stabilize the tumor suppressor PDCD4.

Authors:  Tanja Grkovic; Johanna S Blees; Magdalena M Bayer; Nancy H Colburn; Cheryl L Thomas; Curtis J Henrich; Megan L Peach; James B McMahon; Tobias Schmid; Kirk R Gustafson
Journal:  Mar Drugs       Date:  2014-08-21       Impact factor: 5.118

Review 10.  New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Roman Manetsch; George A O'Doherty; James E Kirby
Journal:  Transl Res       Date:  2020-03-02       Impact factor: 7.012

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.